文献速递区域麻醉与超声术前评估与围术期医学

IPACK阻滞与选择性胫神经阻滞用于全膝关节置换术后镇痛的三盲随机对照试验

Infiltration between the popliteal artery and the capsule of the knee (IPACK) vs. selective tibial nerve block for analgesia after total knee arthroplasty: a triple-blinded randomised controlled trial.
PubMed 文献 · Anaesthesia · 2026-10-18

该三盲随机对照试验纳入90例脊麻下联合股三角阻滞行全膝关节置换术患者,比较IPACK阻滞(19 ml 0.2%罗哌卡因)与选择性胫神经阻滞(5 ml 0.75%罗哌卡因)的镇痛效果。主要结局术后第1天累积静脉吗啡消耗量两组相似(6 (7) mg vs. 5 (6) mg,p=0.36),结论为两种阻滞镇痛效果相当。

要点

  • IPACK与选择性胫神经阻滞术后第1天吗啡消耗量无显著差异。
  • 选择性胫神经阻滞组4例(9%)出现腓总神经运动阻滞。
  • 两组在疼痛评分、股四头肌力量、行走距离和关节活动度方面无差异。

核心结论

  • 在脊麻联合股三角阻滞的全膝关节置换术中,IPACK与选择性胫神经阻滞提供相似的镇痛效果。

研究设计与样本

  • 三盲随机对照试验,共分析90例患者(每组45例),均于脊麻下联合股三角阻滞行全膝关节置换术。

主要发现

  • 术后第1天累积静脉吗啡消耗量IPACK组为6 (7) mg,选择性胫神经阻滞组为5 (6) mg,p=0.36。
  • 选择性胫神经阻滞组4例(9%)出现腓总神经运动阻滞。
  • 两组在术后第1、2、3天静息及运动疼痛评分、股四头肌力量、行走距离和关节活动度方面无其他差异。

关键数值与推荐

  • IPACK组使用19 ml 0.2%罗哌卡因,选择性胫神经阻滞组使用5 ml 0.75%罗哌卡因。
  • 术后镇痛方案包括对乙酰氨基酚、布洛芬和静脉吗啡患者自控镇痛。
  • 主要结局为术后第1天累积静脉吗啡消耗量。

临床怎么用

  • IPACK与选择性胫神经阻滞均可用于全膝关节置换术后后膝镇痛,选择时可权衡腓总神经运动阻滞风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Infiltration between the popliteal artery and the capsule of the knee (IPACK) and the selective tibial nerve block provide analgesia for the posterior aspect of the knee after total knee arthroplasty. This randomised controlled triple-blinded trial tested the hypothesis that IPACK provides superior analgesia to selective tibial nerve block after total knee arthroplasty. METHODS: Patients having total knee arthroplasty under spinal anaesthesia with a femoral triangle block were allocated randomly to receive either IPACK with 19 ml ropivacaine 0.2% or a selective tibial nerve block with 5 ml ropivacaine 0.75%. The postoperative analgesic strategy included paracetamol; ibuprofen; and intravenous morphine patient-controlled analgesia. Primary outcome was cumulative intravenous morphine consumption on postoperative day 1. Secondary analgesic outcomes included pain scores at rest and during movement measured on postoperative days 1, 2 and 3. Functional outcomes were quadriceps strength; walking distance; and range of motion. RESULTS: In total, data from 90 patients were analysed (45 allocated to each group). Cumulative intravenous morphine consumption on postoperative day 1 was similar between the patients allocated to the IPACK and selective tibial nerve block groups (mean (SD) 6 (7) mg vs. 5 (6) mg, respectively; p = 0.36). Four patients (9%) who received selective tibial nerve block had motor block of the common peroneal nerve. No other differences were seen between groups in secondary outcomes. DISCUSSION: The IPACK and selective tibial nerve block provide similar analgesia after total knee arthroplasty under spinal anaesthesia with a femoral triangle block. WHAT WE DID: We studied 90 patients having total knee replacement. All patients had a spinal anaesthetic and another nerve block. They were then randomly given one of two different nerve blocks to reduce pain at the back of the knee. We compared how much morphine they needed, their pain levels and how well they could move their leg and walk. WHY WE DID IT: Pain at the back of the knee can be a problem after knee replacement. Two different nerve blocks, called an IPACK block and a tibial nerve block, can help control this pain. We wanted to find out which one worked better. WHAT WE FOUND: Both nerve blocks gave similar pain relief. Patients in both groups needed about the same amount of morphine during the first day after surgery. There were also no important differences in pain, leg strength, walking distance or knee movement. However, four patients who received the tibial nerve block had temporary weakness in another nerve in the leg. Overall, neither nerve block was better than the other for pain relief after knee replacement.

来源:Anaesthesia,查看原文。版权归原作者所有。

引用

  1. Szyszko M, Wegrzyn J, Rossel JB, et al. Infiltration between the popliteal artery and the capsule of the knee (IPACK) vs. selective tibial nerve block for analgesia after total knee arthroplasty: a triple-blinded randomised controlled trial. Anaesthesia. 2026. PMID: 42893970. doi:10.1111/anae.70434

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。